Committed under
Optimeos Life Sciences, Inc.
$600,000 committed in all years on record · 0.0% of the program
- Full records
- Optimeos Life Sciences, Inc. → everything they’re paid, across every program and agencyAllergy and Infectious Diseases Research → the whole program, every recipientDepartment of Health and Human Services → everything they pay out
By fiscal year
Allergy and Infectious Diseases Research dollars committed to Optimeos Life Sciences, Inc., per fiscal year.
Awards
The largest awards to Optimeos Life Sciences, Inc. under this program.
In Vivo Targeted Delivery of Nucleic Acids to Hematopoietic Stem Cells for Treating Primary Immunodeficiencies - Summary in This Phase I Sbi…
Aug 19, 2025$300,000
Targeted Delivery of Nucleic Acid Formulations for in Vivo Car-treg Generation - in This Phase I Sbir, Optimeos Will Develop an Off-the-shel…
How to read these numbers
- Just these two
Every figure is money committed to this recipient under this one program — nothing they get anywhere else, from this program or any other.
- Totals by action year
The aggregates reflect the fiscal year picked at the top, counted in the year each action happened.
- “Active in FY X”
The award list shows every award between the two with an action that year, at its full lifetime value — so a single award's amount can top that year's committed total.
- From FY2018 on
Pairing pages start at fiscal year 2018, the first year of complete assistance reporting.
- The colored bars
Every bar on this page splits by how the money moves:
Direct paymentsGrants
